drugset / Trial / NCT03735316
Vitamin B12a Vasoplegic Syndrome
RandomizedParallel-groupTriple-blindSupportive care
Summary
The study team will evaluate the medication Hydroxocobalamin (B12a) for treatment of low blood pressure after cardiac surgery.
Timeline
- Start
- 2019-04-25
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxocobalamin | Unknown | 5 g | Intravenous |
Indications
No indication recorded.